Patent · US Active

Compounds

US7803833B2 · kind B2 · utility

8Cited by
3References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 6, 2006
Grant dateSep 28, 2010
Priority date
Expiry dateDec 9, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to quaternary α-aminocarboxyamide derivatives of formula (I), wherein R1, R2, R3, R4, R5, R6, X, q and n are as defined in claim 1, for treating diseases and conditions mediated by modulation of voltage-gated sodium channels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.